BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1 AND Treatment
21 results:

  • 1. The tumor-repressing effect of CYP27A1 on renal cell carcinoma by 27-HC arising from cholesterol metabolism.
    Zhang X; Yin X; Dai J; Sun G; Zhang H; Liang J; Zhao J; Zhu S; Chen J; Zhu X; Ni Y; Wang Z; Liu Z; Chen N; Shen P; Zeng H
    FASEB J; 2022 Sep; 36(9):e22499. PubMed ID: 35969149
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. treatment Patterns, Outcomes, and Costs Associated With Localized Upper Tract Urothelial Carcinoma.
    Fero KE; Shan Y; Lec PM; Sharma V; Srinivasan A; Movva G; Baillargeon J; Chamie K; Williams SB
    JNCI Cancer Spectr; 2021 Dec; 5(6):. PubMed ID: 34805743
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical outcome of renal cancer patients who early interrupted immunotherapy due to serious immune-related adverse events. Meet-Uro 13 trial on behalf of the MeetUro investigators.
    Stellato M; Procopio G; De Giorgi U; Maruzzo M; Bimbatti D; Mennitto A; Sbrana A; Roviello G; Casadei C; Sepe P; Pignata S; Santini D
    J Transl Med; 2021 Aug; 19(1):328. PubMed ID: 34344414
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Bilateral Nephroblastoma with Dilated Cardiomyopathy as an Indication for Off-Protocol treatment: A Case Report.
    Sosnowska-Sienkiewicz P; Gowin E; Jończyk-Potoczna K; Mańkowski P; Godziński J; Januszkiewicz-Lewandowska D
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33352828
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Familial and Hereditary Forms of Primary Hyperparathyroidism.
    Cetani F; Saponaro F; Borsari S; Marcocci C
    Front Horm Res; 2019; 51():40-51. PubMed ID: 30641519
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Metformin Induces Growth Inhibition and Cell Cycle Arrest by Upregulating MicroRNA34a in Renal Cancer Cells.
    Xie W; Wang L; Sheng H; Qiu J; Zhang D; Zhang L; Yang F; Tang D; Zhang K
    Med Sci Monit; 2017 Jan; 23():29-37. PubMed ID: 28045889
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Multiple Endocrine Neoplasia I (Wermers Syndrome), Forms of Clinical Manifestation, 5 Case Studies].
    Drbalová K; Herdová K; Krejčí P; Nývltová M; Solař S; Vedralová L; Záruba P; Netuka D; Bavor P
    Vnitr Lek; 2016; 62(9 Suppl 3):140-149. PubMed ID: 27734708
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells.
    Yan-Fang T; Zhi-Heng L; Li-Xiao X; Fang F; Jun L; Gang L; Lan C; Na-Na W; Xiao-Juan D; Li-Chao S; Wen-Li Z; Pei-Fang X; He Z; Guang-Hao S; Yan-Hong L; Yi-Ping L; Yun-Yun X; Hui-Ting Z; Yi W; Mei-Fang J; Lin L; Jian N; Shao-Yan H; Xue-Ming Z; Xing F; Jian W; Jian P
    PLoS One; 2015; 10(7):e0126566. PubMed ID: 26176219
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Carfilzomib is an effective anticancer agent in anaplastic thyroid cancer.
    Mehta A; Zhang L; Boufraqech M; Zhang Y; Patel D; Shen M; Kebebew E
    Endocr Relat Cancer; 2015 Jun; 22(3):319-29. PubMed ID: 25972243
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways.
    Mitsui Y; Hirata H; Arichi N; Hiraki M; Yasumoto H; Chang I; Fukuhara S; Yamamura S; Shahryari V; Deng G; Saini S; Majid S; Dahiya R; Tanaka Y; Shiina H
    Oncotarget; 2015 Apr; 6(11):9577-91. PubMed ID: 25797254
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Alternative therapeutic approach to renal-cell carcinoma: induction of apoptosis with combination of vitamin K3 and D-fraction.
    Degen M; Alexander B; Choudhury M; Eshghi M; Konno S
    J Endourol; 2013 Dec; 27(12):1499-503. PubMed ID: 24341344
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Tetrandrine triggers apoptosis and cell cycle arrest in human renal cell carcinoma cells.
    Chen T; Ji B; Chen Y
    J Nat Med; 2014 Jan; 68(1):46-52. PubMed ID: 23564030
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Clinical controlled trial of first-line treatment for advanced kidney cancer].
    Zheng ZD; Qu SX; Liu YY; Hao H; Zhang GJ; Xie XD
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(42):2984-7. PubMed ID: 23328290
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Noncytotoxic differentiation treatment of renal cell cancer.
    Negrotto S; Hu Z; Alcazar O; Ng KP; Triozzi P; Lindner D; Rini B; Saunthararajah Y
    Cancer Res; 2011 Feb; 71(4):1431-41. PubMed ID: 21303982
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets.
    Gadd S; Sredni ST; Huang CC; Perlman EJ;
    Lab Invest; 2010 May; 90(5):724-38. PubMed ID: 20212451
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. FOXO1 and TCF7L2 genes involved in metastasis and poor prognosis in clear cell renal cell carcinoma.
    Kojima T; Shimazui T; Horie R; Hinotsu S; Oikawa T; Kawai K; Suzuki H; Meno K; Akaza H; Uchida K
    Genes Chromosomes Cancer; 2010 Apr; 49(4):379-89. PubMed ID: 20095040
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitors.
    Algar EM; Muscat A; Dagar V; Rickert C; Chow CW; Biegel JA; Ekert PG; Saffery R; Craig J; Johnstone RW; Ashley DM
    PLoS One; 2009; 4(2):e4482. PubMed ID: 19221586
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo.
    Sjölund J; Johansson M; Manna S; Norin C; Pietras A; Beckman S; Nilsson E; Ljungberg B; Axelson H
    J Clin Invest; 2008 Jan; 118(1):217-28. PubMed ID: 18079963
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix.
    Inamoto T; Yamochi T; Ohnuma K; Iwata S; Kina S; Inamoto S; Tachibana M; Katsuoka Y; Dang NH; Morimoto C
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3470-7. PubMed ID: 16740772
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. IL-4 inhibits proliferation of renal carcinoma cells by increasing the expression of p21WAF1 and IRF-1.
    Yu SJ; Kim HS; Cho SW; Sohn J
    Exp Mol Med; 2004 Aug; 36(4):372-9. PubMed ID: 15365257
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.